skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
gp100:154-162 Peptide Vaccine (Code C2764)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: gp100:154-162 Peptide Vaccine

Definition: A peptide consisting of amino acid residues 154 through 162 of the melanoma-melanocyte antigen gp100. Vaccination with gp100:154-162 peptide may enhance tumor-specific T-cell immunity. gp100 antigen is a self-antigen expressed by melanocytes, pigmented retinal cells, and most melanoma lesions and is recognized via class I and II HLA-restricted mechanisms.

Label: gp100:154-162 Peptide Vaccine

NCI Thesaurus Code: C2764 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL053051  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
gp100:154-162 Peptide
gp100:154-162 Peptide Vaccine

External Source Codes: 
NSC Code 676540 (see NCI DTP info)
PDQ Closed Trial Search ID 630596
PDQ Open Trial Search ID 630596 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C2764
Legacy_Concept_Name gp100_154-162_Peptide
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom